NCT07722923 Effects of Box Breathing Exercise in Patients With Fibromyalgia
| NCT ID | NCT07722923 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Artvin Coruh University |
| Condition | Fibromyalgia |
| Study Type | INTERVENTIONAL |
| Enrollment | 60 participants |
| Start Date | 2026-09-14 |
| Primary Completion | 2027-09-15 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 60 participants in total. It began in 2026-09-14 with a primary completion date of 2027-09-15.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Fibromyalgia is a chronic condition that can cause widespread pain, sleep problems, fatigue, gastrointestinal symptoms, and reduced comfort. This study will evaluate whether box breathing exercise improves sleep quality, pain, gastrointestinal symptoms, and comfort in patients with fibromyalgia. A total of 60 participants will be randomly assigned to either an intervention group or a control group. Participants in the intervention group will continue their routine treatment and perform box breathing exercises for 10 minutes twice daily for 30 days. Participants in the control group will continue their routine treatment without receiving the breathing exercise. Sleep quality, pain, gastrointestinal symptoms, and comfort will be assessed at the beginning and at the end of the 30-day study period
Eligibility Criteria
Inclusion Criteria: * Aged 18 years or older * Having a diagnosis of fibromyalgia * Having a Visual Analog Scale pain score of 5 or higher * Having a Pittsburgh Sleep Quality Index score of 5 or higher * Being able to communicate and complete the study assessments * Voluntarily agreeing to participate and providing informed consent Exclusion Criteria: * Having a respiratory condition such as asthma or chronic obstructive pulmonary disease * Having a communication problem that prevents participation in the study procedures or completion of the assessment tools
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07722923 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Fibromyalgia. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07722923 currently recruiting?
Yes, NCT07722923 is actively recruiting participants. Contact the research team at emreerkal@hotmail.de for enrollment information.
Where is the NCT07722923 trial being conducted?
This trial is being conducted at Çorum, Turkey (Türkiye).
Who is sponsoring the NCT07722923 clinical trial?
NCT07722923 is sponsored by Artvin Coruh University. The trial plans to enroll 60 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.